Actively Recruiting

Age: 18Years +
All Genders
ID07378137

A Preference Study Comparing the Components of Composite Endpoints for Healthcare Providers and Patients With Coronary Artery Disease

Led by Xijing Hospital · Updated on 2026-01-30

600

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying how patients and medical staff value different components of composite endpoints often used in cardiovascular clinical trials, especially for coronary artery disease (CAD). The study aims to better understand the relative importance of events like myocardial infarction, stroke, and others compared to death, as opinions may differ between patients and healthcare providers. This observational study will help clarify how weighting these endpoints could improve trial interpretations. Participants include patients with acute or chronic coronary syndrome who have undergone percutaneous coronary intervention, as well as healthcare providers treating CAD. Both groups will complete a questionnaire that assesses how they weigh various clinical events relative to death. The study focuses on collecting and comparing these preferences to understand any differences. Participants will complete the questionnaire before hospital discharge. The study measures the relative weights assigned to myocardial infarction, stroke, cardiopulmonary resuscitation, procedural complications, major bleeding, acute kidney injury, revascularization, and rehospitalization compared to death. This observational process involves no treatment but gathers data on preferences, with total involvement lasting from enrollment until questionnaire completion before discharge.

CONDITIONS

Brief Title

Comparing the Components of Composite Endpoints for Healthcare Providers and Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with acute or chronic coronary syndrome who have undergone percutaneous coronary intervention
  • Patients who can understand the purpose of this trial and are willing to participate in the preference questionnaire
  • Healthcare providers who treat patients with coronary artery disease
Not Eligible

You will not qualify if you...

  • Younger than 18 years old
  • Unable to understand the questionnaire or with cognitive impairment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Before discharge

Participants complete a questionnaire regarding the weights given to individual components of the composite endpoint in coronary artery disease.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Xijing Hospital

Xi'an, Shaanxi, China, 710032

Actively Recruiting

Loading map...

Research Team

R

Ruining Zhang, BSc

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Elut...

Elevated Lipoprotein(a) Level

Actively Recruiting

1 location

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

A Longitudinal Cohort of Patients With Acute Coronary Syndro...

Acute Coronary Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here